Literature DB >> 21624505

Toll like receptors in diseases of the lung.

Melissa A Kovach1, Theodore J Standiford.   

Abstract

The lung is in continuous contact with a diverse array of infectious agents, foreign antigens, and host-derived danger signals. To sample this expansive internal and external milieu, both resident myeloid and stromal/structure cells of the lung express a full complement of toll like receptors (TLRs) which recognize pathogen-associated molecular patterns (PAMPs) and endogenous danger-associated molecular patterns (DAMPs). TLRs play a vital role in immune host defense against bacterial, mycobacterial, fungal, and viral pathogens of the lung. Additionally, TLRs contribute to disease pathogenesis in non-infectious pulmonary disorders, including airway disease, acute lung injury, and interstitial lung disease. In this review, TLR biology in the context of experimental infectious and non-infectious lung disease is discussed, and correlates to human lung disease, including therapeutic implications of these findings, are defined.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624505      PMCID: PMC3575025          DOI: 10.1016/j.intimp.2011.05.013

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  117 in total

1.  MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans.

Authors:  Carmelo Biondo; Angelina Midiri; Luciano Messina; Francesco Tomasello; Gabriella Garufi; Maria Rosaria Catania; Mauro Bombaci; Concetta Beninati; Giuseppe Teti; Giuseppe Mancuso
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

2.  IFN-gamma production by innate immune cells is sufficient for development of hypersensitivity pneumonitis.

Authors:  Stephanie Nance; Richard Cross; Ae-Kyung Yi; Elizabeth A Fitzpatrick
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

3.  Th2-biased immune responses are important in a murine model of chronic hypersensitivity pneumonitis.

Authors:  Keiko Mitaka; Yasunari Miyazaki; Makito Yasui; Masashi Furuie; Shuji Miyake; Naohiko Inase; Yasuyuki Yoshizawa
Journal:  Int Arch Allergy Immunol       Date:  2010-09-21       Impact factor: 2.749

4.  Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma.

Authors:  Charoula Xirakia; Ourania Koltsida; Athanasios Stavropoulos; Artemis Thanassopoulou; Vassilis Aidinis; Paschalis Sideras; Evangelos Andreakos
Journal:  Am J Respir Crit Care Med       Date:  2010-03-11       Impact factor: 21.405

5.  TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure.

Authors:  Elisabetta Pace; Antonino Giarratano; Maria Ferraro; Andreina Bruno; Liboria Siena; Salvatore Mangione; Malcolm Johnson; Mark Gjomarkaj
Journal:  Hum Immunol       Date:  2010-10-01       Impact factor: 2.850

6.  Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Authors:  Reuben Ramphal; Viviane Balloy; Jeevan Jyot; Amrisha Verma; Mustapha Si-Tahar; Michel Chignard
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus.

Authors:  Shawn J Skerrett; H Denny Liggitt; Adeline M Hajjar; Christopher B Wilson
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

8.  TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.

Authors:  Gerrit John; Ali O Yildirim; Bruce K Rubin; Dieter C Gruenert; Markus O Henke
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-05       Impact factor: 6.914

9.  Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis.

Authors:  Amrita D Joshi; Daniel J Fong; Sameer R Oak; Glenda Trujillo; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam
Journal:  Am J Respir Crit Care Med       Date:  2009-01-16       Impact factor: 21.405

10.  Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen.

Authors:  Stephanie C Eisenbarth; Damani A Piggott; James W Huleatt; Irene Visintin; Christina A Herrick; Kim Bottomly
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

View more
  36 in total

1.  Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.

Authors:  Rachel Z Blumhagen; Brenna R Hedin; Kenneth C Malcolm; Ellen L Burnham; Marc Moss; Edward Abraham; Tristan J Huie; Jerry A Nick; Tasha E Fingerlin; Scott Alper
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

2.  Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion.

Authors:  Gi S Yoon; Sudha Sud; Rahul K Keswani; Jason Baik; Theodore J Standiford; Kathleen A Stringer; Gus R Rosania
Journal:  Mol Pharm       Date:  2015-06-05       Impact factor: 4.939

3.  Toll-like receptors and diseases.

Authors:  Pablo Iribarren; Ji Ming Wang
Journal:  Int Immunopharmacol       Date:  2011-08-30       Impact factor: 4.932

4.  A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis.

Authors:  N J Bernard; C M Finlay; G M Tannahill; J P Cassidy; L A O'Neill; K H G Mills
Journal:  Mucosal Immunol       Date:  2014-12-17       Impact factor: 7.313

Review 5.  The lung communication network.

Authors:  Davide Losa; Marc Chanson
Journal:  Cell Mol Life Sci       Date:  2015-06-23       Impact factor: 9.261

6.  Epigenetic Regulation of Tolerance to Toll-Like Receptor Ligands in Alveolar Epithelial Cells.

Authors:  Jacqueline Neagos; Theodore J Standiford; Michael W Newstead; Xianying Zeng; Steven K Huang; Megan N Ballinger
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

Review 7.  Nonmicrobial-mediated inflammatory airway diseases--an update.

Authors:  Polani B Ramesh Babu; P Krishnamoorthy
Journal:  J Physiol Biochem       Date:  2013-11-29       Impact factor: 4.158

8.  Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages.

Authors:  Huy A Nguyen; Murugesan V S Rajaram; Douglas A Meyer; Larry S Schlesinger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-10       Impact factor: 5.464

9.  Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis.

Authors:  Peng Lu; Chhinder P Sodhi; David J Hackam
Journal:  Pathophysiology       Date:  2013-12-22

10.  Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.

Authors:  Christina C N Wu; Brian Crain; Shiyin Yao; Mojgan Sabet; Fitzgerald S Lao; Rommel I Tawatao; Michael Chan; Donald F Smee; Justin G Julander; Howard B Cottam; Donald G Guiney; Maripat Corr; Dennis A Carson; Tomoko Hayashi
Journal:  J Innate Immun       Date:  2013-11-01       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.